As a deep tech fund, we come across a fair share of platform-tech startups. The promise of supposedly expandable market opportunities is auspicious for growth and return. Though oftentimes, many fall into execution traps, especially earlier on in the life cycle.
While some missteps may be reversible, others exhaust already limited resources and lead to a point of no return.
The underlying macrotrends, current solutions and investment opportunities Creative Ventures recently led an investment into VenoStent, an advanced-material technology company working on eliminating the 50%+ failure rate in vascular-access surgery required to initiate hemodialysis. Here we unravel the underlying macrotrends driving the development of solutions and investment opportunities in this sector. The kidneys are amongContinue reading “Kidney Disease: A Silent (and Costly) Killer”